Analyst Ratings for Cytokinetics (CYTK)
CYTK Rating Summary
CYTK Price Target Summary
- Highest: $122.00 (B.Riley)
- Lowest: $48.00 (JPMorgan)
- Average: $79.77
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$79.77 (+23.1%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
Avg. $ Target:
$79.77 (+23.1%)
* Over Last 12-Mos
Rating Score: 8.6 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/24/2024 | UBS | Ashwani Verma | Downgrade | Neutral (Buy) |
92.00 (61.00) |
84.80 (64.80) |
-23.58% | Details |
| 1/5/2024 | Morgan Stanley | Jeffrey Hung | Downgrade | Equalweight (Overweight) |
90.00 (60.00) |
86.64 (64.80) |
-25.21% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
